erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.
...
suicidal thoughts, attempts on the rise among young people: 'it's a critical public-health crisis right now'..